166 related articles for article (PubMed ID: 1898737)
1. Synthesis and secretion of plasminogen activator inhibitor 1 by human endothelial cells in vitro. Effect of active site mutagenized tissue-type plasminogen activator.
Bartha K; Declerck PJ; Moreau H; Nelles L; Collen D
J Biol Chem; 1991 Jan; 266(2):792-7. PubMed ID: 1898737
[TBL] [Abstract][Full Text] [Related]
2. Binding of tissue-type plasminogen activator with human endothelial cell monolayers. Characterization of the high affinity interaction with plasminogen activator inhibitor-1.
Russell ME; Quertermous T; Declerck PJ; Collen D; Haber E; Homcy CJ
J Biol Chem; 1990 Feb; 265(5):2569-75. PubMed ID: 2105930
[TBL] [Abstract][Full Text] [Related]
3. Interaction of wild-type and catalytically inactive mutant forms of tissue-type plasminogen activator with human umbilical vein endothelial cell monolayers.
Ramakrishnan V; Sinicropi DV; Dere R; Darbonne WC; Bechtol KB; Baker JB
J Biol Chem; 1990 Feb; 265(5):2755-62. PubMed ID: 2105933
[TBL] [Abstract][Full Text] [Related]
4. On the reversible interaction of plasminogen activator inhibitor-1 with tissue-type plasminogen activator and with urokinase-type plasminogen activator.
Lijnen HR; Van Hoef B; Collen D
J Biol Chem; 1991 Mar; 266(7):4041-4. PubMed ID: 1900284
[TBL] [Abstract][Full Text] [Related]
5. Oxygen radicals generated during anoxia followed by reoxygenation reduce the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cell culture.
Shatos MA; Doherty JM; Stump DC; Thompson EA; Collen D
J Biol Chem; 1990 Nov; 265(33):20443-8. PubMed ID: 2122975
[TBL] [Abstract][Full Text] [Related]
6. The majority of type 1 plasminogen activator inhibitor associated with cultured human endothelial cells is located under the cells and is accessible to solution-phase tissue-type plasminogen activator.
Schleef RR; Podor TJ; Dunne E; Mimuro J; Loskutoff DJ
J Cell Biol; 1990 Jan; 110(1):155-63. PubMed ID: 2104856
[TBL] [Abstract][Full Text] [Related]
7. Heparin enhances active site-dependent binding of tissue-type plasminogen activator to endothelial cells.
Rosenfeld L; Kuo A; Hirsh J; Klugherz B; Gardell SJ; Cines DB; Barnathan ES
Blood; 1992 Sep; 80(6):1486-95. PubMed ID: 1520875
[TBL] [Abstract][Full Text] [Related]
8. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals.
Shatos MA; Doherty JM; Orfeo T; Hoak JC; Collen D; Stump DC
J Biol Chem; 1992 Jan; 267(1):597-601. PubMed ID: 1730619
[TBL] [Abstract][Full Text] [Related]
9. Suppression of plasminogen activator inhibitor 1 release by fibrin from human umbilical vein endothelial cells.
Fukao H; Ueshima S; Tanaka N; Okada K; Matsuo O
Thromb Res Suppl; 1990; 10():11-20. PubMed ID: 2107596
[TBL] [Abstract][Full Text] [Related]
10. Determinants of induction of increased synthesis of plasminogen activator inhibitor type-1 in human endothelial cells by t-PA.
Fujii S; Sobel BE
Thromb Haemost; 1992 Feb; 67(2):233-8. PubMed ID: 1621243
[TBL] [Abstract][Full Text] [Related]
11. Interaction of tissue-type plasminogen activator and plasminogen activator inhibitor 1 on the surface of endothelial cells.
Sakata Y; Okada M; Noro A; Matsuda M
J Biol Chem; 1988 Feb; 263(4):1960-9. PubMed ID: 3123483
[TBL] [Abstract][Full Text] [Related]
12. Induction of synthesis of plasminogen activator inhibitor type-1 by tissue-type plasminogen activator in human hepatic and endothelial cells.
Fujii S; Lucore CL; Hopkins WE; Billadello JJ; Sobel BE
Thromb Haemost; 1990 Nov; 64(3):412-9. PubMed ID: 2128971
[TBL] [Abstract][Full Text] [Related]
13. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells.
Thompson EA; Nelles L; Collen D
Eur J Biochem; 1991 Nov; 201(3):627-32. PubMed ID: 1935958
[TBL] [Abstract][Full Text] [Related]
14. Cell-specific regulation of plasminogen activator inhibitor 1 and tissue type plasminogen activator release by human kidney mesangial cells.
Peraldi MN; Rondeau E; Medcalf RL; Hagège J; Lacave R; Delarue F; Schleuning WD; Sraer JD
Biochim Biophys Acta; 1992 Apr; 1134(3):189-96. PubMed ID: 1558843
[TBL] [Abstract][Full Text] [Related]
15. Identification of determinants involved in binding of tissue-type plasminogen activator-plasminogen activator inhibitor type 1 complexes to HepG2 cells.
Morton PA; Owensby DA; Wun TC; Billadello JJ; Schwartz AL
J Biol Chem; 1990 Aug; 265(24):14093-9. PubMed ID: 2167306
[TBL] [Abstract][Full Text] [Related]
16. Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1, and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes c-jun and c-fos.
Kooistra T; Bosma PJ; Toet K; Cohen LH; Griffioen M; van den Berg E; le Clercq L; van Hinsbergh VW
Arterioscler Thromb; 1991; 11(4):1042-52. PubMed ID: 1648385
[TBL] [Abstract][Full Text] [Related]
17. Thrombin regulation of mRNA levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in cultured human umbilical vein endothelial cells.
Dichek D; Quertermous T
Blood; 1989 Jul; 74(1):222-8. PubMed ID: 2502201
[TBL] [Abstract][Full Text] [Related]
18. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression. Interaction with cAMP and protein kinase C-mediated pathways.
Konkle BA; Kollros PR; Kelly MD
J Biol Chem; 1990 Dec; 265(35):21867-73. PubMed ID: 1701436
[TBL] [Abstract][Full Text] [Related]
19. Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1.
Li XK; Lijnen HR; Nelles L; Van Hoef B; Stassen JM; Collen D
Blood; 1992 Jan; 79(2):417-29. PubMed ID: 1730087
[TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo.
van Hinsbergh VW; Kooistra T; van den Berg EA; Princen HM; Fiers W; Emeis JJ
Blood; 1988 Nov; 72(5):1467-73. PubMed ID: 3140909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
